Dietary and exercise intervention for patients with metabolic dysfunction associated steatotic liver disease (MASLD): a systematic review and meta-analysis.
Introduction: A metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is one of the most common causes of chronic liver disease.1 MASLD currently affects around 30% of adults worldwide and is attributed to be the leading caus...
Saved in:
Main Authors: | Binika Gurung, Sujita Gurung, Nwe Ni (Sophia) Than |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-07-01
|
Series: | Clinical Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825001009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)
by: Laiba Shakeel, et al.
Published: (2025-06-01) -
Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Chieh Liu, et al.
Published: (2025-07-01) -
Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review
by: Vignesh Rajan, et al.
Published: (2025-07-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evolving Insights into Pathogenesis, Progression, and Personalized Treatment Approaches
by: Paweł Kukiełka, et al.
Published: (2025-07-01) -
Metabolic dysfunction-associated steatotic liver disease (MASLD): emerging insights into gut microbiota interactions and therapeutic perspectives
by: Wenchu Qian, et al.
Published: (2025-06-01)